Abstract 527: Isolation of large and diverse monoclonal antibody panels against the multipass membrane protein targets Kv1.3, P2X7, and Claudin 18.2
Abstract Monoclonal antibodies (MAbs) are a well-established treatment approach in oncology and other diseases. Nevertheless, multipass membrane proteins are largely inaccessible as MAb targets due to their poor expression, membrane-dependent structure, small extracellular regions, and high sequence...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 80; no. 16_Supplement; p. 527 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
15.08.2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!